Malabsorption as a Cause of Iron Treatment Failure in Infants

HaEmek Medical Center, Israel

Status: Completed

Conditions: Iron Deficiency; Malabsorption

Treatments: Drug: Metronidazole; Procedure: Blood tests

Study type: Interventional

Funder types: Other

Identifiers

NCT00456729

4150905.EMC

Details and patient eligibility

About

Infants should receive prophylacatic iron supplementation since age 4 months till one year. Patients suffering from malabsorption, mainly Giardia infestation may develop iron deficiency resistent to further iron treatment. The purpose of this study is to assess the incidence of malabsorption in those infants and to examine the results of empiric treatment with metronidazole.

Sex: All

Ages: 6 months to 4 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• All infants referred to the Pediatric Hematology Unit because lack of response to iron treatment.

Exclusion criteria

• Patients diagnosed with specific malabsorption causes like Celiac or Cystic Fibrosis.

Trial design

Primary purpose: Diagnostic

Allocation: Non-Randomized

Interventional model: Single Group Assignment

Masking: None (Open label)